当前位置: X-MOL 学术Pol. Arch. Intern. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Optimum duration of dual antiplatelet therapy followed by monotherapy for diabetes after percutaneous coronary intervention with drug-eluting stent implantation: a Bayesian network meta-analysis.
Polish Archives of Internal Medicine ( IF 5.218 ) Pub Date : 2021-06-16 , DOI: 10.20452/pamw.16032
Ke An 1, 2 , Peng Guo 3 , Shanhu Qiu 1, 2 , Wenwen Zhu 1, 2 , Wuyou Cao 1, 2 , Jijing Shi 1, 2 , Shaohua Wang 4
Affiliation  

The standard 12-month dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation that is recommend for the general population may not be suitable for diabetes patients.

中文翻译:

经皮冠状动脉介入药物洗脱支架植入后糖尿病双联抗血小板治疗后单药治疗的最佳持续时间:贝叶斯网络荟萃分析。

推荐用于一般人群的经皮冠状动脉介入治疗 (PCI) 和药物洗脱支架 (DES) 植入后的标准 12 个月双重抗血小板治疗 (DAPT) 可能不适合糖尿病患者。
更新日期:2021-07-06
down
wechat
bug